Cipla’s India business that contributes 42% to overall revenue grew 10% YoY to Rs 2817 crore in Q2FY24 with continued momentum across branded prescription, trade generics and consumer health verticals
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
